Esteve Pharmaceuticals, S.A.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Esteve Pharmaceuticals, S.A.
Three years after the US FDA released a guidance to use real-world evidence in premarket applications, the stakeholder group MDIC has unveiled a framework for how IVD RWE can be captured and used by sponsors for premarket applications.
Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…
Japan’s Towa has completed its €329m deal for the Pensa Investments generics business of Spain’s Esteve.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
- Contract Manufacturing Organization
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- Esteve Teijin Healthcare (ETH)
- Laboratorios del Dr. Esteve, S.A.